SOPH
SOPHiA GENETICS S.A.
NASDAQ · Healthcare · Medical - Healthcare Information Services · CH
$8.16
−1.69%Margins
Gross margin
66.6%
EBITDA margin
-75.6%
EBIT margin
-85.0%
Net margin
-93.9%
FCF margin
-53.0%
-97.3%
Return on equity
-40.8%
Return on assets
-50.5%
Return on invested capital
0.48x
Asset turnover
-$41.6M
Cash from operations
$1.26
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026